Sort by:

select Language:



Stratégie mondiale du secteur de la santé contre l'hépatite virale 2016-2021: vers l'élimination de l'hépatite virale

Organisation mondiale de la Santé (OMS), (2016)


Le présent document énonce la première stratégie mondiale du secteur de la santé contre l’hépatite virale, une stratégie qui contribue à la réalisation du Programme de développement durable à l’horizon 2030.
Elle couvre les six premières années du plan d’action pour la santé de l’après-2015, c’est-à-dire la période 2016-2021, en s’appuyant sur le document Prévention et lutte contre l’hépatite virale : cadre pour l’action mondiale et sur deux résolutions relatives à l’hépatite virale adoptées par l’Assemblée mondiale de la Santé en 2010 et en 2014.
Cette stratégie porte sur les cinq virus de l’hépatite (les hépatites A, B, C, D et E), en mettant plus spécialement l’accent sur les hépatites B et C en raison de la lourde charge relative qu’elles représentent pour la santé publique.
http://apps.who.int/iris/bitstream/handle/10665/25...


Global health sector strategy on viral hepatitis 2016-2021: Towards ending viral hepatitis

World Health Organization (WHO), (2016)


This is the first global health sector strategy on viral hepatitis, a strategy that contributes to the achievement of the 2030 Agenda for Sustainable Development.
It covers the first six years of the post-2015 health agenda, 2016–2021, building on the Prevention and Control of Viral Hepatitis Infection: Framework for Global Action, and on two resolutions on viral hepatitis adopted by the World Health Assembly in 2010 and in 2014.
The strategy addresses all five hepatitis viruses (hepatitis A, B, C, D and E), with a particular focus on hepatitis B and C, owing to the relative public health burden they represent.
http://apps.who.int/iris/bitstream/handle/10665/24...


Waterborne Outbreaks of Hepatitis E: recognition, investigation and control

World Health Organization (WHO), (2014)


Technical report
This manual aims to provide information about the methods for investigating outbreaks of hepatitis E, and measures for their prevention and control. In addition, the manual gives information about the causative agent – known as the hepatitis E virus (HEV) – its epidemiology, clinical manifestations of the disease and diagnosis.
http://apps.who.int/iris/bitstream/handle/10665/12...


Guidelines for the screening, care and treatment of persions with hepatitis C infection. Updated Version, April 2016

World Health Organization WHO, (2016)


The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV genotype and clinical history, and assess the appropriateness of continued use of certain medicines. This document also includes existing recommendations on screening for HCV infection and care of persons infected with HCV that were first issued in 2014
http://apps.who.int/iris/bitstream/10665/205035/1/...


Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection

World Health Organization, (2015)


The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of nucleos(t)ide analogues with a high barrier to drug resistance (tenofovir and entecavir, and entecavir in children aged 2–11 years) for first- and second-line treatment. Recommendations for the treatment of HBV/HIV-coinfected persons are based on the WHO 2013 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, which will be updated in 2015.
http://apps.who.int/iris/bitstream/10665/154590/1/...


Short Guide to Hepatitis C

Stefan Mauss, Thomas Berg, Jürgen Rockstroh et al., Eds.: Flying Publisher, (2014)


Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students.
http://pdf.flyingpublisher.com/HepatitisC_Guide_20...


Hepatitis B (chronic): Diagnosis and management of chronic hepatitis B in children, young people and adults

Aftab Ala, Elizabeth Boxall, Steven Bradley et al., Eds.: National Clinical Guideline Centre, (2013)


Clinical guideline, Methods, Evidence and Recommendations In this guideline the following is covered: information needs of people with chronic hep titis B and their carers; where children, young people and adults with chronic hepatitis B a- should be assessed; assessment of liver disease, including the use of non-invasive tests and genotype testing; criteria for offering antiviral treatment; the efficacy, safety and cost effectiveness of currently available treatments; selection of first-line therapy; management of treatment failure or drug resistance; prophylactic treatment during im- munosuppressive therapy; and monitoring for treatment response
http://www.ncbi.nlm.nih.gov/books/NBK254250/pdf/TO...


7 hits